Press release
Radiopharmacies Market Outlook Highlights Strategic Opportunities Across The Industry
Radiopharmacies Market
Radiopharmacies Market Size and Projected Growth Through 2030
The radiopharmacies market is anticipated to experience robust growth, reaching a valuation of $15.26 billion by 2030. This growth reflects a compound annual growth rate (CAGR) of 8.2%. Factors contributing to this expansion include the rapid development of targeted radionuclide therapies, heightened investments in PET and SPECT imaging technologies, and the broader adoption of personalized medicine. Additionally, the establishment of centralized radiopharmacy networks and the increased demand for sophisticated radiopharmaceutical logistics and cold chain solutions are key drivers. Prominent trends shaping the market include a growing preference for targeted oncology therapies, wider use of centralized dose preparation services, stricter attention to radiation safety and regulatory standards, and expanding nuclear medicine applications in cardiology and neurology. Investments in enhanced quality control and assurance systems for radiopharmaceutical handling are also gaining momentum.
Download a free sample of the radiopharmacies market report:
https://www.thebusinessresearchcompany.com/sample_request?id=77240583&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jun_PR
Critical Factors Fueling Demand in Radiopharmacies
One major factor propelling the radiopharmacies market is the rising focus on targeted radiopharmaceutical therapies, particularly in oncology. These therapies enable more precise treatment options, improving patient outcomes and driving market demand.
Another important driver is the increasing adoption of centralized radiopharmacy services that streamline dose preparation. These centralized networks enhance efficiency, reduce errors, and facilitate compliance with safety standards, making them attractive to healthcare providers.
Key Industry Players Dominating the Radiopharmacies Market
The radiopharmacies sector features several leading companies, including Cardinal Health Inc., Siemens Healthineers AG, GE HealthCare Technologies Inc., BWX Technologies Inc., and Bracco Imaging S. p. A. Other notable players include Lantheus Holdings Inc., China Isotope & Radiation Corporation, Ion Beam Applications S. A. (IBA), Telix Pharmaceuticals Limited, Eckert & Ziegler Strahlen, PharmaLogic Holdings Corp., Shine Technologies LLC, NTP Radioisotopes SOC Ltd., NorthStar Medical Radioisotopes LLC, ITM Isotope Technologies Munich SE, ARTBIO Inc., Isotopia Molecular Imaging Ltd., AdvanCell Isotopes Pty Ltd., Futurechem Co. Ltd., Jubilant Radiopharma Pvt. Ltd., Cyclotek (Aust) Pty Ltd., Radiomedix Inc., Iso-Tex Diagnostics Inc., and Nucleus RadioPharma Inc.
View the full radiopharmacies market report:
https://www.thebusinessresearchcompany.com/report/radiopharmacies-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jun_PR
Strategic Acquisition Expands Telix Pharmaceuticals' Market Reach
In January 2025, Telix Pharmaceuticals Limited, an Australia-based healthcare technology company, acquired RLS (USA) Inc., a U.S.-based firm specializing in radiopharmacies. Although the financial details were undisclosed, this acquisition aims to create an integrated radiopharmaceutical ecosystem. With this, Telix plans to enhance delivery of innovative therapeutic and diagnostic products across the U.S., streamline supply chain operations, accelerate clinical programs, and broaden patient access to cutting-edge imaging and treatment solutions.
Innovations Transforming Radiopharmacies Production Capabilities
Leading companies in the market are investing in advanced radiopharmaceutical production facilities to boost manufacturing efficiency and ensure a steady supply of high-quality diagnostic and therapeutic agents. These specialized centers focus on precision, safety, and scalability for producing radioactive compounds used in medical imaging and therapy.
For example, in October 2024, PharmaLogic Holdings Corp. inaugurated a state-of-the-art production facility in Los Angeles. This facility features automated synthesis modules, rigorous quality controls, and scalable production lines, enabling consistent manufacture of PET and SPECT imaging agents. The upgrades reduce human error, minimize contamination risks, and improve turnaround times compared to traditional labs, supporting a reliable supply chain for critical imaging agents.
The Largest Segments Within the Radiopharmacies Market
This market is segmented by product type into diagnostic and therapeutic radiopharmaceuticals. Diagnostic types include Single Photon Emission Computed Tomography (SPECT) radiopharmaceuticals, Positron Emission Tomography (PET) agents, bone imaging, cardiac imaging, and renal imaging radiopharmaceuticals. Therapeutic segments cover radioiodine therapy, radiolabeled antibody therapy, peptide receptor radionuclide therapy, bone pain palliation, and liver cancer therapy agents.
Service types include radiopharmaceutical compounding, dose preparation, drug dispensing, quality control, radiation safety management, logistics and delivery, inventory management, regulatory compliance support, and consulting and training services.
The market also breaks down by radioisotope types such as technetium-based, fluorine-based, iodine-based, gallium-based, lutetium-based, and others.
Applications range across oncology, cardiology, neurology, endocrinology, and other medical fields, with end users comprising hospitals, diagnostic imaging centers, research institutes, and specialty clinics.
Outlook on Radiopharmacy Market Expansion
With ongoing advancements in imaging technologies, personalized treatment, and centralized services, the radiopharmacies market is positioned to maintain strong growth through 2030. Innovations in production and safety measures, alongside strategic partnerships and acquisitions, will further drive this expansion, offering improved patient care and operational efficiencies across healthcare systems worldwide.
The 2026 edition of our market reports now delivers enhanced analytical coverage through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Radiopharmacies Market Outlook Highlights Strategic Opportunities Across The Industry here
News-ID: 4559632 • Views: …
More Releases from The Business Research Company
Viral Diagnostic Test Kits Market Insights Highlight Segment Expansion And Marke …
The viral diagnostic test kits market is gaining significant traction as the world focuses more on pandemic preparedness and rapid disease detection. Innovations in testing technology and a rising need for decentralized healthcare solutions are driving this sector forward. Let's explore the market size, key players, emerging trends, and segment details shaping the future of viral diagnostic testing.
Projected Market Growth for Viral Diagnostic Test Kits
The viral diagnostic test…
Vertebroplasty Needles Market Report Evaluates Growth Drivers, Challenges And Ma …
The vertebroplasty needles market is set for remarkable growth as demand for spine-related procedures rises globally. With advancements in surgical techniques and a growing elderly population, this sector is poised to expand significantly in the coming years. Let's explore the expected market size, key drivers, leading players, and segmentation details that define this evolving landscape.
Projected Market Size Growth for Vertebroplasty Needles by 2030
The vertebroplasty needles market is anticipated…
Ventricular Assist Device Market Report Provides Insights Into Market Evolution …
The ventricular assist device market is gaining significant traction as advancements in cardiovascular technology continue to evolve. Driven by demographic changes and innovations in device design, this sector is set to experience substantial growth and transformation over the coming years. Let's explore the current market size, key players, emerging trends, and detailed segment analysis that define this dynamic industry.
Projected Market Size and Growth of the Ventricular Assist Device Market …
Vein Illumination Devices Market Research Explores Growth Within A $1.05 Billion …
The vein illumination devices market is poised for remarkable expansion as advancements in medical imaging technology continue to enhance patient care. With a growing focus on non-invasive procedures and improved accuracy in intravenous access, this sector is attracting significant attention from healthcare providers and technology developers alike. Below, we explore the market's valuation, key players, segmentation, and the main drivers behind its growth.
Projected Market Value and Growth of the Vein…
More Releases for Radiopharma
Nuclear Pharmacy Market Future Business Opportunities 2025-2032 | Curium Pharma, …
The Latest study titled Nuclear Pharmacy Market 2025, published by Coherent Market Insights, provides valuable insights into both regional and global markets projected to grow in value from 2025 to 2032. The comprehensive research delves into the evolving market dynamics, value chain analysis, prominent investment areas, competitive landscape, regional outlook, and key market segments. It also offers a thorough assessment of the global market's drivers and constraints. Additionally, the report…
Actinium Pharmaceuticals (ATNM) Garners Attention with Clinical Successes and St …
Actinium's Chief Medical Officer, said, "In addition to demonstrating unprecedented 100% access to BMT in Iomab-B treated patients with active r/r AML and achieving the primary endpoint of dCR with high statistical significance, we are excited by the compelling outcomes in patients with a TP53 mutation in the SIERRA trial. We look forward to returning to EBMT and once again highlighting the positive results from the Phase 3 SIERRA trial…
Actinium Pharmaceuticals (ATNM): A Prime Buyout Candidate Amidst a Radiopharma A …
Biotech Stocks Taking Centerstage
As the pharmaceutical industry ventures deeper into the era of precision medicine, radiopharmaceuticals, particularly those involving alpha emitters like Actinium-225 (Ac-225), are gaining prominence for their targeted approach to cancer treatment. Amid this innovative surge, Actinium Pharmaceuticals (NYSE:ATNM) emerges not just as a company with a promising pipeline but as a beacon of cutting-edge manufacturing capabilities that could very well position it as a prime buyout candidate…
2030 Projections: Radiopharmaceutical Synthesizers Market to Deliver Dynamic Pro …
The Radiopharmaceutical Synthesizers Market Research Report 2023-2030 provides in-depth information on market trends, market capacity, industry size, growth factors, share, innovations, competitive environment, business problems, and more. This report's historical data confirms demand growth on a global, national, and regional scale. The studies on the global industry cover everything from comprehensive research to market size and forecasting to dynamics, growth factors, prospects, and hazards, as well as vendor knowledge. The…
Automated Radiosynthesis Modules Market Strategic Assessment & SWOT Analysis 202 …
An Informative report titled as Global Automated Radiosynthesis Modules Market has recently been published by Report Consultant to its online repository. This statistical data offers an in-depth analysis by considering several segments, such as type, size, technology and applications. Different exploratory techniques such as, qualitative and quantitative analysis have been used to give data accurately. For better understanding of the customers, it uses effective graphical presentation techniques, such as graphs,…
Cyclotron Market Growth Opportunities Analysis Report | GE Healthcare, Siemens H …
Cyclotron Market: Introduction
According to the report, the global cyclotron market was valued at US$ 215.5 Mn in 2019. It is projected to expand at a CAGR of ~3% from 2020 to 2030. Expansion activities of key radiopharma players; applications in clinical trials; increase in the geriatric population; pipeline assessment of new drugs; and disease indication mortality are major factors driving the cyclotron market. The shutdown of a few nuclear reactors has led to the…
